Literature DB >> 29497576

Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series.

Sandeep Grover1, Aditya Somani1, Neeru Sahni1, Sahil Mehta1, Swati Choudhary1, Rahul Kumar Chakravarty1, Anju Moni Rabha1.   

Abstract

Depression is a common comorbidity in patients suffering from Parkinson's disease (PD). Available evidence suggests that electroconvulsive therapy (ECT) is an effective treatment for depression and also improves symptoms of PD. However, literature on usefulness of ECT in parkinsonian symptoms is limited. A review of records of all patients receiving ECT from 2010 to April 2017 in the authors' clinic yielded six cases (0.63% of all patients who received ECT at the authors' center over last 7 years) of depression with PD who were treated with ECT. All six patients had improvement in both depression and symptoms of PD following ECT treatment. The improvement achieved with ECT was sustained in four patients. Worsening of PD symptoms 3 to 4 months post-treatment was seen in two patients. ECT appears to be an effective treatment option for management of motoric symptoms in patients with PD, especially those with comorbid psychiatric disorders.

Entities:  

Keywords:  Depression; Parkinson’s disease; electroconvulsive therapy

Year:  2018        PMID: 29497576      PMCID: PMC5819717     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  24 in total

1.  Maintenance ECT in the treatment of PD. Therapy improves psychotic symptoms, physical function.

Authors:  Robert B Shulman
Journal:  Geriatrics       Date:  2003-11

Review 2.  Depression and Parkinson's disease: a review.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

3.  ECT and delirium in Parkinson's disease.

Authors:  G S Figiel
Journal:  Am J Psychiatry       Date:  1992-12       Impact factor: 18.112

4.  Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.

Authors:  Satoshi Ueda; Keiko Koyama; Yoshiro Okubo
Journal:  J ECT       Date:  2010-06       Impact factor: 3.635

Review 5.  Depression in Parkinson's disease -- a review.

Authors:  A Lieberman
Journal:  Acta Neurol Scand       Date:  2006-01       Impact factor: 3.209

6.  Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.

Authors:  Suneetha K Sadananda; Bharath Holla; Biju Viswanath; Aniruddh Narasimha; Ami Sebastian; Suresh B Math; Channapatna R Chandrashekar
Journal:  J ECT       Date:  2013-03       Impact factor: 3.635

7.  Efficacy of ECT in severe obsessive-compulsive disorder with Parkinson's disease.

Authors:  Amin Muhammad Gadit; Thomas Smigas
Journal:  BMJ Case Rep       Date:  2012-04-04

8.  Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms.

Authors:  Kenya Nishioka; Ryota Tanaka; Hideki Shimura; Kazuoki Hirano; Taku Hatano; Koichi Miyakawa; Heii Arai; Nobutaka Hattori; Takao Urabe
Journal:  J Neural Transm (Vienna)       Date:  2014-04-18       Impact factor: 3.575

9.  An estimate of the incidence of depression in idiopathic Parkinson's disease.

Authors:  G Dooneief; E Mirabello; K Bell; K Marder; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1992-03

10.  Bifrontal ECT for drug-induced psychosis in Parkinson's disease.

Authors:  K Muralidharan; R Thimmaiah; V Chakraborty; S Jain
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

View more
  2 in total

Review 1.  Electroconvulsive Therapy and Movement Disorders. New Perspectives on A Time-Tested Therapy.

Authors:  Pedro J Garcia Ruiz
Journal:  Mov Disord Clin Pract       Date:  2021-03-09

2.  Treatment of Catatonia in Parkinson's Disease with Electroconvulsive Therapy.

Authors:  Vinutha Ramesh; Ashish Sharma; Veenita Sharma; Aditya Somani
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.